-
Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:11-cv-00717
- D. Del.
- Judge: Renee Marie Bumb
+1
- Filed: 08/16/2011
- Closed: 06/20/2014
- Latest Docket Entry: 08/23/2019
- PACER
1
Plaintiff
4
Defendants
1
Accused
Product
3
Patents-in-Suit
1,040
Days in
Litigation
-
Endo Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. et al DC CAFC
- 1:11-cv-00717
- D. Del.
- Judge: Renee Marie Bumb
+1
- Filed: 08/16/2011
- Closed: 06/20/2014
- Latest Docket Entry: 08/23/2019
- PACER
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A compound of formula (I) which is 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, or a salt, solvate or hydrate thereof.
|
Valid (101 and 102 and 103 and 112)
Entry 226 |
| 2 |
A method of treatment of a condition wherein a 5-HT.sub.1 -like agonist is indicated, which comprises administering to a subject in need thereof an effective amount of a compound of claim 1.
|
Valid (101 and 102 and 103 and 112)
Entry 226 |
| 3 |
The method according to claim 1 wherein the condition is migraine.
|
Valid (101 and 102 and 103 and 112)
Entry 226 |
| 6 |
A pharmaceutical composition comprising the compound according to claim 1, or a physiologically acceptable salt thereof and a physiologically acceptable carrier.
|
Valid (101 and 102 and 103 and 112)
Entry 226 |